The Vanguard Health Care Fund (Trades, Portfolio), which invests at least 80% of its assets in stocks of companies principally related to the health care industry, bought shares of the following stocks in both the second and third quarters.
The fund increased its position by 17.36% in the second quarter and then raised it by 4.17% in the third quarter. The stock has a weight of 2.45% in the portfolio.
The American managed-care organization has a market cap of $68.90 billion. Its revenue of $100.17 billion has grown at an average rate of 8.60% per annum over the last five years.
Andreas Halvorsen (Trades, Portfolio) is the largest guru shareholder of the company with 2.03% of outstanding shares, followed by Barrow, Hanley, Mewhinney & Strauss with 1.49% and First Eagle Investment (Trades, Portfolio) with 0.66%.
Vanguard increased its stake by 20.82% in the second quarter and added 5.69% in the third quarter. The stock has a weight of 2.17% in the portfolio.
The generic pharmaceutical manufacturer has a market cap of $10.18 billion. Its revenue of $11.28 billion has grown at an average annual rate of 5.0% over the last five years.
Another notable guru shareholder of the company is Richard Pzena (Trades, Portfolio) with 3.76% of outstanding shares, followed by John Paulson (Trades, Portfolio) with 2.13% and First Pacific Advisors (Trades, Portfolio) with 1.18%.
Teva Pharmaceutical Industries Ltd. (TEVA, Financial)
The Health Care Fund increased its holding by 15.79% in the second quarter and by 41.11% in the third quarter. The stock has a total weight of 1.04% in the portfolio.
The company, which develops and sells branded pharmaceuticals, has a market cap of $9.61 billion. Its revenue of $17.72 billion has fallen 4.20% on average every year over the last five years.
Warren Buffett (Trades, Portfolio) is another notable guru shareholder of the company with 3.96% of outstanding shares, followed by David Abrams (Trades, Portfolio) with 1.65% and Jim Simons (Trades, Portfolio)' Renaissance Technologies with 0.90%.
In the second quarter, the fund increased its position by 52.48% and then boosted it by 33.52% in the third quarter. The stock has a weight of 0.78% in the portfolio.
The company, which provides government-sponsored health care plans, has a market cap of $40.12 billion. Its revenue of $60.72 billion has grown 8.40% on average every year over the last five years.
The largest guru shareholder of the company is Simons’ firm with 2.18% of outstanding shares, followed by Larry Robbins (Trades, Portfolio) with 1.30% and Lee Ainslie (Trades, Portfolio) with 1.15%.
Alkermes PLC (ALKS, Financial)
Vanguard bolstered its position by 23.98% in the second quarter and by 0.46% in the third quarter. The stock has a weight of 0.61% in the portfolio.
The biotechnology company has a market cap of $3.18 billion. Its revenue of $1.07 billion has grown at an average annual rate of 11.20% over the last five years.
The largest guru shareholder of the company is PRIMECAP Management (Trades, Portfolio) with 14.80% of outstanding shares, followed by Simons’ firm with 2.51%, Paul Tudor Jones (Trades, Portfolio) with 0.10% and Steven Cohen (Trades, Portfolio) with 0.08%.
Centene Corp. (CNC, Financial)
In the second quarter, the fund raised its stake by 20.66% and by 15.28% in the third quarter. The stock has a weight of 0.48% in the portfolio.
The American health care plans provider has a market cap of $21.40 billion. Its revenue of $72.33 billion has grown 25.90% on average every year over the last five years.
The largest guru shareholder of the company is Halvorsen with 4.03% of outstanding shares, followed by Ainslie with 1.77% and Daniel Loeb (Trades, Portfolio) with 0.72%.
Amneal Pharmaceuticals Inc. (AMRX, Financial)
The fund increased its position by 2.24% in the second quarter and by 25.38% in the third quarter. The stock has a weight of 0.06% in the portfolio.
The drugmaker has a market cap of $1.09 billion.
Another notable guru shareholder of the company is Cohen with 1.11% of outstanding shares, followed by the Simons’ firm with 0.02% and Joel Greenblatt (Trades, Portfolio) with 0.01%.
Disclosure: I do not own any stocks mentioned.
Read more here:
- David Carlson Trims Charles Schwab, Exits Verizon
- Diamond Hill Continues to Buy Baidu, Deere
- Kahn Brothers Trims Merck, Exits Sterling Bancorp
Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.
